VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 64 filers reported holding VENTYX BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,474,564 | +18.2% | 2,662,671 | +11.7% | 0.00% | 0.0% |
| Q2 2023 | $78,220,292 | +29.2% | 2,384,765 | +31.9% | 0.00% | 0.0% |
| Q1 2023 | $60,558,118 | +23.4% | 1,807,705 | +20.8% | 0.00% | +100.0% |
| Q4 2022 | $49,059,448 | +27.3% | 1,496,171 | +35.5% | 0.00% | 0.0% |
| Q3 2022 | $38,539,000 | +247.5% | 1,103,953 | +21.7% | 0.00% | – |
| Q2 2022 | $11,091,000 | +71.4% | 906,939 | +90.2% | 0.00% | – |
| Q1 2022 | $6,471,000 | -31.7% | 476,862 | -0.0% | 0.00% | – |
| Q4 2021 | $9,473,000 | – | 476,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |